|Articles|December 1, 2001

December 2001
Volume 7
Issue 12

Leading the Way: Managed Care for Patients Near the End of Life

Author(s)Mildred Z. Soloman, EdD

Download PDF: Leading the Way: Managed Care for Patients Near the End of Life

Articles in this issue

over 24 years ago

Article

A Pneumonia Practice Guideline and a Hospitalist-Based Reorganization Lead to Equivalent Efficiency Gains

over 24 years ago

Article

Financial Risk, Plans Types, and Authorizations for Managed Alcohol Treatment Services

over 24 years ago

Article

The Greater Acceptance and Utilization of Nurse Practitioners

over 24 years ago

Article

End-of-life Care: A Public Health Crisis and an Opportunity for Managed Care

over 24 years ago

Article

Fall History Is an Independent Predictor of Adverse Health Outcomes and Utilization in the Elderly

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Leading the Way: Managed Care for Patients Near the End of Life

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Semaglutide More Than Doubled Likelihood of MASH Resolution

Once-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites

Everyday Discrimination Linked to Health Care Access Barriers, Lower Preventive Care

GLP-1 Receptor Agonists Linked to Lower Fracture Risk in T2D

Early Remdesivir May Protect Kidney Transplants After COVID-19: Nitipong Permpalung, MD, MPH